newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision ...